ResMed|

RMD · New York Stock Exchange · Health Care

☆ Follow

Shareholder advocacy aimed at ResMed|

Nothing recorded yet. That means no campaign in our database names this company, not that none exists.

What shareholders voted on

From ResMed|’s own filings with the SEC. Support is the share of votes cast for and against, so abstentions and broker non-votes are not counted in it.

2025

2024

2023

2022

2021

2020

2019

ItemKindAsked for bySupportOutcome
Item No.3: Approve, on an advisory basis, the compensation of ResMed’s named executive officersSay on pay88.5%Passed
Election of Jan De WitteDirector99.9%Passed
Election of Carol BurtDirector98.8%Passed
Election of Rich SulpizioDirector96.5%Passed

2018

2017

Proxy statements and vote results

Straight from ResMed|’s own SEC filings. The proxy statement lists what shareholders were asked to vote on; the 8-K certifies how the vote went.

YearFilingFiled
2025Vote results2025-11-20
2025Proxy statement2025-10-02
2024Vote results2024-11-21
2024Proxy statement2024-10-03
2023Vote results2023-11-20
2023Proxy statement2023-10-05
2022Vote results2022-11-17
2022Proxy statement2022-10-05
2021Vote results2021-11-19
2021Proxy statement2021-10-06
2020Vote results2020-11-20
2020Proxy statement2020-10-06
2019Vote results2019-11-22
2019Proxy statement2019-10-08
2018Vote results2018-11-16
2018Proxy statement2018-10-03
2017Vote results2017-11-17
2017Proxy statement2017-09-25

Do you represent ResMed|? Claim this profile to respond to the campaigns listed here.

← All companies